Global Hypoactive Sexual Desire Disorder Treatment Market to Reach US$ 3.7 Billion by 2032, Impelled by Increasing Acceptance of Sexual Wellness Treatments

March 15, 2023 | Healthcare

According to the latest report by IMARC Group, titled "Hypoactive Sexual Desire Disorder Treatment Market Report by Therapy (Buspirone, Bupropion, Testosterone, Flibanserin, Bremelanotide, Cognitive Behavior Therapy), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Hospitals, Clinics, and Others), and Region 2024-2032," the global hypoactive sexual desire disorder treatment market reached a value of US$ 2.5 Billion in 2023. Hypoactive sexual desire disorder (HSDD) is a medical condition characterized by low sexual desire and decreased interest in sexual activity. The treatment of HSDD varies and may include a combination of medications, therapies, and lifestyle changes. Psychotherapy and sex therapy can help individuals with HSDD explore the emotional and psychological factors contributing to their low sexual desire. Couples therapy can also help address relationship issues affecting sexual desire. Making lifestyle changes, such as reducing stress, improving sleep habits, and engaging in regular physical activity, may help improve sexual desire. HSDD is a complex condition due to which its treatment is often tailored to each individual's specific needs and circumstances.

Global Hypoactive Sexual Desire Disorder Treatment Market Trends:

The global market is majorly driven by the increasing prevalence of hypoactive sexual desire disorder (HSDD). In line with this, the rising awareness of HSDD as a medical condition and the availability of new treatment options are significantly contributing to the market growth. Furthermore, the growing acceptance of sexual wellness products and treatments is positively influencing the market. Apart from this, the escalating geriatric population, which is more prone to sexual dysfunction, is catalyzing the growth of the market. Moreover, the increasing focus on research and development of new drugs and therapies for HSDD is propelling the market. Besides, the launch of new and more effective treatment solutions is strengthening the market. Additionally, the rising working women population and their hectic work schedules may result in low libido conditions, thereby providing a boost to the demand for HSDD treatment. Some of the other factors driving the market include the growing healthcare expenditure, escalating levels of stress, and the availability of advanced therapeutics. On account of the factors above, the market is anticipated to reach a value of US$ 3.7 Billion by 2032, exhibiting a CAGR of 4.52% during 2024-2032.

Market Summary:

On the basis of the therapy, the market has been categorized into buspirone, bupropion, testosterone, flibanserin, bremelanotide, and cognitive behavior therapy.
Based on the distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies.
Based on the application, the market has been segmented into hospitals, clinics, and others.
On the basis of the region, the market has been divided into North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others) and the Middle East and Africa (Saudi Arabia, Iran, Turkey, and others).
The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market. Some of the key players include Allergan Plc, AMAG Pharmaceuticals, Inc., Emotional Brain BV, Endoceutics, Inc., GlaxoSmithKline Plc, Ovoca Bio Plc, Pivot Pharmaceuticals, Inc., Palatin Technologies, Inc., S1 Biopharma, Inc., and Sprout Pharmaceuticals, Inc.

Report Scope:

Report Features	Details
Base Year of the Analysis	2023
Historical Period	2018-2023
Forecast Period	2024-2032
Units	US$ Billion
Segment Coverage	Therapy, Distribution Channel, Application, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, United Kingdom, Germany, France, Spain, Italy, Russia, China, Japan, India, South Korea, Saudi Arabia, Iran, Turkey, Brazil, Mexico
Companies Covered	Allergan Plc, AMAG Pharmaceuticals, Inc., Emotional Brain BV, Endoceutics, Inc., GlaxoSmithKline Plc, Ovoca Bio Plc, Pivot Pharmaceuticals, Inc., Palatin Technologies, Inc., S1 Biopharma, Inc., and Sprout Pharmaceuticals, Inc.
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 3899 Five User License: US$ 4899 Corporate License: US$ 5899
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Hypoactive Sexual Desire Disorder Treatment Market to Reach US$ 3.7 Billion by 2032, Impelled by Increasing Acceptance of Sexual Wellness Treatments

Purchase options

Single User License ~~$3899~~ $2999
Five User License ~~$4899~~ $3999
Corporate User License ~~$5899~~ $4999

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.